NFKB1 and aortic aneurysm: Here, the biomarker findings were in line with previous preclinical studies, which have shown that treatment with a GLP-1 RA attenuates aortic aneurysm in mice, in part through the regulation of MMP levels and by preventing NF-κB-driven inflammation [11,12,13,14,15,16,17,18].